(Q43986034)

English

Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

0 references

Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions (English)

1 reference

Europe PubMed Central

28 November 2017

0 references

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Norihiro Nishimoto

1

1 reference

Europe PubMed Central

28 November 2017

Kyoko Ito

2

1 reference

Europe PubMed Central

28 November 2017

Nobuhiro Takagi

3

1 reference

Europe PubMed Central

28 November 2017

publication date

11 March 2010

1 reference

Europe PubMed Central

28 November 2017

Modern Rheumatology

1 reference

Europe PubMed Central

28 November 2017

20

1 reference

Europe PubMed Central

28 November 2017

3

1 reference

Europe PubMed Central

28 November 2017

222-232

1 reference

Europe PubMed Central

28 November 2017

Interleukin 6: from bench to bedside

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0279-5

21 January 2018

Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism.

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0279-5

21 January 2018

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0279-5

21 January 2018

Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0279-5

21 January 2018

Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibi

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0279-5

21 January 2018

Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study.

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0279-5

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0279-5

21 January 2018

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0279-5

21 January 2018

Masked early symptoms of pneumonia in patients with rheumatoid arthritis during tocilizumab treatment: a report of two cases.

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0279-5

21 January 2018

Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0279-5

21 January 2018

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0279-5

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-010-0279-5

21 January 2018

Identifiers

10.3109/S10165-010-0279-5

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43986034&oldid=2105320606"